130 related articles for article (PubMed ID: 2542177)
1. Processing and secretion of envelope glycoproteins of human immunodeficiency virus type 1 in the presence of trimming glucosidase inhibitor deoxynojirimycin.
Pal R; Kalyanaraman VS; Hoke GM; Sarngadharan MG
Intervirology; 1989; 30(1):27-35. PubMed ID: 2542177
[TBL] [Abstract][Full Text] [Related]
2. Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.
Pal R; Hoke GM; Sarngadharan MG
Proc Natl Acad Sci U S A; 1989 May; 86(9):3384-8. PubMed ID: 2541446
[TBL] [Abstract][Full Text] [Related]
3. A unique human immunodeficiency virus culture secreting soluble gp160.
Kalyanaraman VS; Pal R; Gallo RC; Sarngadharan MG
AIDS Res Hum Retroviruses; 1988 Oct; 4(5):319-29. PubMed ID: 3264172
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of novel 1-deoxynojirimycin derivatives on HIV-1 replication.
Shimizu H; Tsuchie H; Yoshida K; Morikawa S; Tsuruoka T; Yamamoto H; Ushijima H; Kitamura T
AIDS; 1990 Oct; 4(10):975-9. PubMed ID: 2148090
[TBL] [Abstract][Full Text] [Related]
5. Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein.
Fenouillet E; Gluckman JC
J Gen Virol; 1991 Aug; 72 ( Pt 8)():1919-26. PubMed ID: 1678778
[TBL] [Abstract][Full Text] [Related]
6. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase.
Gruters RA; Neefjes JJ; Tersmette M; de Goede RE; Tulp A; Huisman HG; Miedema F; Ploegh HL
Nature; 1987 Nov 5-11; 330(6143):74-7. PubMed ID: 2959866
[TBL] [Abstract][Full Text] [Related]
7. Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis.
Fenouillet E; Clerget-Raslain B; Gluckman JC; Guétard D; Montagnier L; Bahraoui E
J Exp Med; 1989 Mar; 169(3):807-22. PubMed ID: 2538547
[TBL] [Abstract][Full Text] [Related]
8. Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport.
Dewar RL; Vasudevachari MB; Natarajan V; Salzman NP
J Virol; 1989 Jun; 63(6):2452-6. PubMed ID: 2542563
[TBL] [Abstract][Full Text] [Related]
9. 6-0-butanoylcastanospermine (MDL 28,574) inhibits glycoprotein processing and the growth of HIVs.
Taylor DL; Sunkara PS; Liu PS; Kang MS; Bowlin TL; Tyms AS
AIDS; 1991 Jun; 5(6):693-8. PubMed ID: 1652979
[TBL] [Abstract][Full Text] [Related]
10. Sulfation of the human immunodeficiency virus envelope glycoprotein.
Bernstein HB; Compans RW
J Virol; 1992 Dec; 66(12):6953-9. PubMed ID: 1433500
[TBL] [Abstract][Full Text] [Related]
11. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.
Willey RL; Bonifacino JS; Potts BJ; Martin MA; Klausner RD
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9580-4. PubMed ID: 2849111
[TBL] [Abstract][Full Text] [Related]
12. Brefeldin A inhibits the processing and secretion of envelope glycoproteins of human immunodeficiency virus type 1.
Pal R; Mumbauer S; Hoke GM; Takatsuki A; Sarngadharan MG
AIDS Res Hum Retroviruses; 1991 Aug; 7(8):707-12. PubMed ID: 1718346
[TBL] [Abstract][Full Text] [Related]
13. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
Raja NU; Vincent MJ; Jabbar MA
J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1.
Kalyanaraman VS; Rodriguez V; Veronese F; Rahman R; Lusso P; DeVico AL; Copeland T; Oroszlan S; Gallo RC; Sarngadharan MG
AIDS Res Hum Retroviruses; 1990 Mar; 6(3):371-80. PubMed ID: 2187500
[TBL] [Abstract][Full Text] [Related]
15. N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure.
Fischer PB; Karlsson GB; Dwek RA; Platt FM
J Virol; 1996 Oct; 70(10):7153-60. PubMed ID: 8794362
[TBL] [Abstract][Full Text] [Related]
16. Recombinant HIV envelope expressed in an alpha-glucosidase I-deficient CHO cell line and its parental cell line in the presence of 1-deoxynojirimycin is functional.
Fenouillet E; Papandréou MJ; Jones IM
Virology; 1997 Apr; 231(1):89-95. PubMed ID: 9143306
[TBL] [Abstract][Full Text] [Related]
17. The alpha-glucosidase inhibitor 1-deoxynojirimycin blocks human immunodeficiency virus envelope glycoprotein-mediated membrane fusion at the CXCR4 binding step.
Papandréou MJ; Barbouche R; Guieu R; Kieny MP; Fenouillet E
Mol Pharmacol; 2002 Jan; 61(1):186-93. PubMed ID: 11752220
[TBL] [Abstract][Full Text] [Related]
18. Expression and immunogenicity of the extracellular domain of the human immunodeficiency virus type 1 envelope glycoprotein, gp160.
Berman PW; Riddle L; Nakamura G; Haffar OK; Nunes WM; Skehel P; Byrn R; Groopman J; Matthews T; Gregory T
J Virol; 1989 Aug; 63(8):3489-98. PubMed ID: 2545918
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus.
Dewar RL; Natarajan V; Vasudevachari MB; Salzman NP
J Virol; 1989 Jan; 63(1):129-36. PubMed ID: 2535720
[TBL] [Abstract][Full Text] [Related]
20. gp160 of HIV-I synthesized by persistently infected Molt-3 cells is terminally glycosylated: evidence that cleavage of gp160 occurs subsequent to oligosaccharide processing.
Merkle RK; Helland DE; Welles JL; Shilatifard A; Haseltine WA; Cummings RD
Arch Biochem Biophys; 1991 Oct; 290(1):248-57. PubMed ID: 1898096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
